Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy

BJU International

Volumn 113, Issue 6, 2014, Pages 894-899

  Ark, Jacob T ^a   Keegan, Kirk A ^a   Barocas, Daniel A ^a   Morgan, Todd M ^a   Resnick, Matthew J ^a   You, Chaochen ^a   Cookson, Michael S ^a   Penson, David F ^a   Davis, Rodney ^a   Clark, Peter E ^a   Smith, Joseph A ^a   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cystectomy; outcome and process assessment (health care); surgical pathology; urinary bladder; urinary bladder neoplasms

Indexed keywords

AGED; ARTICLE; BLADDER MUSCLE; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER UNDERSTAGING; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDRONEPHROSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; MUSCULARIS PROPRIA; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT HISTORY OF CHEMOTHERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; TRANSURETHRAL RESECTION;

CYSTECTOMY; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SURGICAL PATHOLOGY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84902280072     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12245     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
2. Malmström PU, Busch C, Norlén BJ,. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 1987; 21: 185-195
3. Dwivedi US, Kumar A, Das SK, et=al. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy. Urol Oncol 2009; 27: 514-519
4. Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS,. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001; 166: 490-493
5. Konety BR, Williams RD,. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 2004; 94: 18-21
6. Lee R, Droller MJ,. The natural history of bladder cancer. Implications for therapy. Urol Clin North Am 2000; 27: 1-13; vii
7. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodríguez J,. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000; 164: 680-684
8. Hall MC, Chang SS, Dalbagni G, et=al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178: 2314-2330
9. Miladi M, Peyromaure M, Zerbib M, Saïghi D, Debré B,. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 2003; 43: 241-245
10. Montie JE, Clark PE, Eisenberger MA, et=al. Bladder cancer. J Natl Compr Canc Netw 2009; 7: 8-39
11. Schwaibold HE, Sivalingam S, May F, Hartung R,. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006; 97: 1199-1201
12. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381
13. Edge SB, Compton CC,. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474
14. Stein JP, Penson DF,. Invasive T1 bladder cancer: indications and rationale for radical cystectomy. BJU Int 2008; 102: 270-275
15. Fritsche H-M, Burger M, Svatek RS, et=al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010; 57: 300-309
16. Stimson CJ, Cookson MS, Barocas DA, et=al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. J Urol 2010; 183: 1732-1737
17. Guzzo TJ, Magheli A, Bivalacqua TJ, et=al. Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology 2009; 74: 1276-1280
18. Herkommer K, Hofer C, Gschwend JE, Kron M, Treiber U,. Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors. J Urol 2012; 187: 1566-1570
19. Balbay MD, Cimentepe E, Unsal A, Bayrak O, Koç A, Akbulut Z,. The actual incidence of bladder perforation following transurethral bladder surgery. J Urol 2005; 174: 2260-2262; discussion 2262-3
20. Nieder AM, Meinbach DS, Kim SS, Soloway MS,. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 2005; 174: 2307-2309
21. Golan S, Baniel J, Lask D, Livne PM, Yossepowitch O,. Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair-clinical characteristics and oncological outcomes. BJU Int 2011; 107: 1065-1068
22. Dalbagni G, Herr HW, Reuter VE,. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002; 60: 822-825
23. Herr HW,. Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 2005; 32: 157-164
24. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J,. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73-78